Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bromocriptine/levodopa Combined Versus Levodopa Alone for Early Parkinson's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439066/0/. Accessed 27 April 2024.
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439066/0/. Accessed April 27, 2024.
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439066/0/
Bromocriptine/levodopa Combined Versus Levodopa Alone for Early Parkinson's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439066/0/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease
ID - 439066
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439066/0/
DB - Evidence Central
DP - Unbound Medicine
ER -